The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

This study assesses the controversial role of temozolomide (TMZ) concurrent with adjuvant radiation (RT) in patients with anaplastic astrocytoma (AA). The impact of isocitrate dehydrogenase (IDH) status on therapy and outcomes is also examined. All adult patients diagnosed with AA from 2001 to 2011...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neurooncol
Auteurs principaux: Kizilbash, Sani H., Giannini, Caterina, Voss, Jesse S., Decker, Paul A., Jenkins, Robert B., Hardie, John, Laack, Nadia N., Parney, Ian F., Uhm, Joon H., Buckner, Jan C.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229369/
https://ncbi.nlm.nih.gov/pubmed/24993250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-014-1520-4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires